Pharmaceutical Industry Articles & Reports - Page 42

Learn the complete history of GLP-1 drugs from the incretin effect to 2026 breakthroughs. Covers exenatide, semaglutide, tirzepatide, oral Wegovy, retatrutide, CagriSema, and the evolution from diabetes to obesity treatment.

An in-depth guide to US drug formularies, pharmacy benefits, and prior authorization (PA). Learn how P&T committees, tiers, ePA systems, and the CMS-0057-F interoperability rule shape drug coverage and costs

Get a complete list of Real-Time Benefits Check (RTBC) modules and providers. Learn how solutions from Surescripts, DrFirst, Arrive Health (formerly RxRevu), GoodRx & more work within EHRs. Updated for 2026.

Learn what a health insurance formulary is. This guide explains the drug list, tiers, and cost-sharing used by PBMs to control prescription costs and access.

An evidence-based analysis of the top 5 electronic prior authorization (ePA) platforms. Compare CoverMyMeds, Surescripts, OptimizeRx, DrFirst & Availity — updated with 2025-2026 CMS-0057-F milestones, Touchless PA, and AI-driven workflows.

Learn about the NCPDP SCRIPT standard, the U.S. foundation for electronic prescribing (e-prescribing). Updated for 2026 with HTI-4 Final Rule, v2023011 migration, and latest Surescripts data.

A technical analysis of cost-effective LLMs (updated March 2026). Compare API pricing, performance benchmarks, and features for Gemini 3.1 Flash-Lite, Claude Haiku 4.5, GPT-5 Mini, Grok 4.1 Fast, DeepSeek V3.2, and more.

Learn the 9 ALCOA+ principles for GxP data integrity. Updated for 2026 with ICH E6(R3) finalization, EU GMP Chapter 4 ALCOA++ draft, and latest FDA enforcement trends

Explore Veeva QualityOne, the unified cloud QMS for regulated industries like CPG & chemicals. Updated for 2026 with AI Agents, LIMS, new modules, and customer case studies.

2026 LLM API price comparison: OpenAI GPT-6, Gemini 3.8 Flash, Claude Opus 5.5, Grok 4.7 and DeepSeek costs per million tokens, updated October 2026.

An educational analysis of AI biotech funding in 2025. Explore venture capital investment trends, funding data, and key deals in AI for drug discovery.

Explore the key drivers behind major pharma and CRO layoffs in 2025-2026. This analysis covers economic pressures, patent cliffs, and R&D shifts at top companie

Analysis of AI medical devices in 2025. Learn about market growth, 950+ FDA-authorized devices, new regulations like the EU AI Act, and key clinical challenges.

Learn what an electronic Investigator Site File (eISF) is and its role in clinical trials. Updated for 2026 with ICH E6(R3) finalization, latest adoption data, and eISF vs. eTMF comparison

Comprehensive guide to Regulatory Information Management (RIM) systems and ISO IDMP standards, covering EMA PMS deadlines, eCTD v4.0 timelines, AI-powered RIM tools, and compliance strategies for life sciences organizations (updated March 2026).

Learn about the TMF Reference Model (now TMF Standard Model under CDISC), the industry-standard taxonomy for organizing Trial Master File documents in clinical trials. Covers TMF SM v1, ICH E6(R3) alignment, and AI-powered eTMF automation.

Updated 2026 guide to finding drugs in the clinical pipeline (Phase I-III). Learn to use ClinicalTrials.gov (550K+ studies), CTIS, commercial databases, and AI-powered tools like Pharmaprojects+ and TuneLab.

Prepare for your life sciences role with our updated 2026 guide to top Veeva Vault interview questions. Covers Vault CRM migration, AI Agents, platform features, and compliance topics

Explore our 2025 analysis of the top 25 pharmaceutical companies by AI patent filings. Learn who leads in AI R&D, key technology areas, and strategic trends.

Learn to design a ChatGPT workshop for biotech professionals. Updated for GPT-5 and 2026 regulatory frameworks, this guide covers LLM fundamentals, practical use cases, and prompt engineering for life sciences.

Updated 2026 framework for validating generative AI in GxP systems. Covers 21 CFR Part 11, EU Annex 22, ISPE GAMP AI Guide, FDA CSA guidance, and FDA-EMA joint AI principles

Explore a technical blueprint for an RWE platform architecture, detailing how to integrate real-world data (RWD) from EMR, claims, and genomics sources. Updated with 2025-2026 developments including EHDS regulation, DARWIN EU progress, and FHIR R5.

Learn about Japan's drug approval process, updated for 2026. This guide covers PMDA & MHLW roles, review timelines, drug lag, the 2025 PMD Act amendments, eCTD v4.0 mandate, and expedited pathways like SAKIGAKE.

Explore the top MCP servers for biotech. Learn how the Model Context Protocol connects AI agents and LLMs to critical databases for genomics and drug discovery.